Endo Pharmaceuticals

Listing Websites about Endo Pharmaceuticals

Filter Type:

Endo A Global Specialty Pharmaceutical Company

(1 days ago) WebEndo is a specialty pharmaceutical company committed to helping everyone we serve live their best life through the delivery of quality, life-enhancing therapies. Our decades of …

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Endo Pharmaceuticals Home

(1 days ago) WebEndo is a specialty pharmaceutical company committed to helping everyone we serve live their best life through the delivery of quality, life-enhancing therapies. Endo has global …

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Endo International - Wikipedia

(8 days ago) Endo was created as a result of a management buyout from DuPont Merck in 1997 led by Carol Ammon. In 2009, Endo bought Indevus Pharmaceuticals to diversify into endocrinology and oncology. The company entered the male hypogonadism market later in 2010 with Fortesta 2% gel. In November 2013, Endo agreed to purchase Paladin Labs Inc for about $1.6 billion to gain access to the Can…

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Endo Pharmaceuticals Inc. Company Information - Drugs.com

(7 days ago) Web30 rows · Drugs Associated with Endo Pharmaceuticals Inc. Endo Pharmaceuticals Inc. manufactures, markets and/or distributes more than 28 drugs in …

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Endo to Cease Production and Sale of Qwo® (collagenase …

(6 days ago) WebEndo (OTC: ENDPQ) is a specialty pharmaceutical company committed to helping everyone we serve live their best life through the delivery of quality, life …

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Kroll Restructuring Administration

(Just Now) WebDebtor Name Endo Pharmaceuticals Inc. Petition Date August 16, 2022 Case Number 22-22592 Debtor Name Endo Pharmaceuticals Solutions Inc. Petition Date August 16, …

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Newsroom Endo International plc

(4 days ago) WebNewsroom. Endo (NASDAQ: ENDP) is a specialty pharmaceutical company committed to helping everyone we serve live their best life through the delivery of quality, …

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Endo Aesthetics Home

(1 days ago) WebWe are grounded in over two decades of pharmaceutical and scientific excellence to push the boundaries of aesthetic artistry. Pursuing rigorous clinical research in the cellulite …

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Press Releases Endo International plc

(8 days ago) WebSummary Toggle ADVANZ PHARMA and Endo Announce Partnership for Paladin Labs to Commercialize Xydalba® (dalbavancin hydrochloride) in Canada. April …

Url: Visit Now

Category:  Health Detail Drugs


Endo Pharmaceuticals Building - Wikipedia

(9 days ago) WebThe Endo Pharmaceuticals Building, also known as “Endo Laboratories”, is a pharmaceutical plant designed by architect Paul Rudolph in 1962 in Garden City, New …

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


ENDO PHARMACEUTICALS Revenue, Growth & Competitor Profile …

(9 days ago) WebDetermine whether Endo Pharmaceuticals grew or shrank during the last recession. This is useful in estimating the financial strength and credit risk of the …

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Endo Pharmaceuticals LinkedIn

(4 days ago) WebEndo Pharmaceuticals is an operating company of Endo International plc (NASDAQ: ENDP), a highly focused generics and specialty branded pharmaceutical company …

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Working at Endo Pharmaceuticals Glassdoor

(7 days ago) WebCompany - Public (ENDP) Industry: Biotech & Pharmaceuticals. Revenue: $1 to $5 billion (USD) Competitors: Unknown. Endo Pharmaceuticals Inc., headquartered in Malvern, …

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Endo International - ENDP Stock Forecast, Price & News

(6 days ago) WebEndo International plc (NASDAQ:ENDP) announced its quarterly earnings results on Thursday, November, 4th. The company reported $0.80 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.46 by $0.34. The firm had revenue of $772.03 million for the quarter, compared to analyst estimates of $667.94 …

Url: Visit Now

Category:  Health Detail Drugs


Endo Pharmaceuticals and Endo Health Solutions to Pay $192.7 …

(1 days ago) WebPharmaceutical company Endo Health Solutions Inc. and its subsidiary Endo Pharmaceuticals Inc. (Endo) have agreed to pay $192.7 million to resolve criminal and civil liability arising from Endo’s marketing of the prescription drug Lidoderm for uses not approved as safe and effective by the Food and Drug Administration (FDA), the …

Url: Visit Now

Category:  Pharmaceutical,  Health Detail Drugs